Circulating CD4⁺CD25⁺ T Regulatory Cells Are Not Altered in Multiple Sclerosis and Unaffected by Disease-Modulating Drugs

By Putheti Prabhakar   Pettersson Asa   Soderstrom Mats   Link Hans   Huang Yu Min  

Journal of Clinical Immunology, Vol. 24, Iss. 2, 2004-03 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

Cyclophosphamide modulates CD4 + T cells into a T helper type 2 phenotype and reverses increased IFN- production of CD8 + T cells in secondary progressive multiple sclerosis

By Karni A.   Balashov K.   Hancock W.W.   Bharanidharan P.   Abraham M.   Khoury S.J.   Weiner H.L.  

Journal of Neuroimmunology, Vol. 146, Iss. 1, 2004-01 ,pp. : 189-198

Elsevier

Access to resources Recommend Favorite

T h 2 bias of CD4 + NKT cells derived from multiple sclerosis in remission

By Araki M.  

International Immunology, Vol. 15, Iss. 2, 2003-02 ,pp. : 279-288

Oxford University Press

Access to resources Recommend Favorite

A biased V 24 + T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease

By Demoulins T.   Gachelin G.   Bequet D.   Dormont D.  

Immunology Letters, Vol. 90, Iss. 2, 2003-12 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Restricted TCR V α gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis

By Zang Y.  

International Immunology, Vol. 10, Iss. 7, 1998-07 ,pp. : 991-998

Oxford University Press

Access to resources Recommend Favorite